AzTrials
AzTrials

Quality of LifeNCT00740038

Support for People Undergoing Chemotherapy

A study testing Stress Management training, Exercise Training and Combined stress management and exercise training in people with Quality of Life and Cancer, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chemotherapy adversely affects quality of life in cancer patients. Both stress management training and exercise training have been shown to improve quality of life. These two types of training have not been directly compared for chemotherapy patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Quality of Life, Cancer
What is being tested?
Stress Management training, Exercise Training and Combined stress management and exercise training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
471 participants
Where
1 siteUnited States
Study dates
Aug 2006to Aug 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be diagnosed with cancer
  • Be scheduled to receive cytotoxic chemotherapy for at least 14 weeks
  • Be ≥18 years of age or older
  • Have an ECOG performance status of 0, 1, or 2
  • Be capable of speaking and reading English
  • Be able to provide informed consent

Who cannot join

  • ECOG of 3 or greater
  • Presence of contraindications to participating in moderate intensity exercise including:
  • . metastases to weight-bearing sites (spine, pelvis, lower extremities)
  • . active infections
  • . cardiomyopathy or congestive heart failure
  • . severe pulmonary or ventilatory disease (FEV 1.0<50%)
Show all 19Show fewer
  • . large pleural effusions or pericardial effusions
  • . anemia (Hgb <8g/dL)
  • . neutropenia (absolute neutrophil count < 0.05 x 10(9th)/L)
  • . severe osteoporosis (> 2.5 SD below age and gender norms)
  • . thrombocytopenia (platelets < 20 x 10(9th)/L)
  • . hyponatremia (Na+ < 130 mmol/L)
  • . hypokalemia (K+ ≤ 3.0 mmol/L)
  • . hypercalcemia (Ca++ > 6.5 mmol/L)
  • . abnormal ECG
  • . sensorimotor deficits sufficient to impede unassisted walking
  • Receipt of intravenous chemotherapy administration in the past 2 months
  • Prescription for chronotropic, sympathomimetic, or inotropic/vasoactive medications
  • Presence of other contraindications as determined by the attending oncologist and research staff

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Moffitt Cancer Center

    Tampa, Florida, 33612

Other trials in United States

About this study

Official title: Study of Stress Management and Exercise Intervention During Cancer Chemotherapy

Chemotherapy adversely affects quality of life in cancer patients. Both stress management training and exercise training have been shown to improve quality of life. These two types of training have not been directly compared for chemotherapy patients.

This study seeks to evaluate the separate and combined effects of stress management training and exercise training on quality of life during chemotherapy treatment. Participants receive either a home-based, self-administered program in 1 of 3 types (stress management, exercise, or stress management + exercise) or usual care (reading materials). It is hypothesized that the combined program (stress management + exercise) will be significantly associated with better quality of life than the usual care group, the exercise only group, and the stress management only group. All participants are assessed at 3 timepoints: before they begin chemotherapy, 6 weeks after their first chemotherapy infusion, and 12 weeks after their first infusion.

Being tested
Stress Management training, Exercise Training, Usual care, Combined stress management and exercise training
Keywords
Stress Management, Quality of Life, Exercise, Cancer, Chemotherapy
Medical subject headings
Neoplasms, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stress Management trainingBehavioural

    Also called Coping techniques, Cognitive-behavioral, stress management, Progressive muscle relaxation

    Self-administered stress management training comprising 10 minute introduction by staff, \& provision of DVD, CD,brochure, and workbook. Materials provide overview of sources of stress during chemotherapy, and instruction in cognitive-behavioral stress management techniques (paced abdominal breathing, progressive muscle relaxation with guided imagery, and use of coping self-statements). Daily use is encouraged over 13-14 weeks of the study.

  • Exercise TrainingBehavioural

    Also called Exercise program, Walking program, home-based exercise, exercise during chemotherapy

    Home-based exercise (walking) program: brief introduction by staff (10 minutes) and provision of packet with DVD, brochure, workbook, pedometer (electronic step counter) along with instructions on initiating and maintaining a walking program. Dose Recommendations: 3-5 exercise session per week for at least 20-30 minutes at maximum intensity of 50 to 75% of their estimated heart rate reserve (RPE of 11-13) which is calculated based on their age and resting pulse.

  • Usual careBehavioural

    Also called Active control group, Information on chemotherapy

    Usual psychosocial care and provision of NCI booklet, Chemotherapy and You (NCI, 1999) which gives general feedback about fitness testing, exercise and stress management during chemotherapy. Recommended to read booklet at least once.

  • Combined stress management and exercise trainingBehavioural

    Also called Stress management and exercise, Exercise and stress management, exercise during chemotherapy, Progressive muscle relaxation

    Home-based, self-administered stress management and exercise (walking) program: brief introduction by staff and provision of DVD, CD, brochure, pedometer, workbook. Dose Recommendations: walking/exercise program (3-5 times per week for at least 20-30 minutes) and use of CD (progressive muscle relaxation with guided imagery) and coping statements once per day.

Study groups in NCT00740038
Study groupRoleWhat they receive
1Active comparatorActive Control: Usual Care
Receives: Behavioral: Usual care
2ExperimentalStress Management Intervention
Receives: Behavioral: Stress Management training
3ExperimentalExercise Intervention
Receives: Behavioral: Exercise Training
4ExperimentalCombined Stress Management and Exercise Intervention
Receives: Behavioral: Combined stress management and exercise training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Medical Outcomes Survey-Short Form (SF-36, acute)

    Measured: pre-chemotherapy baseline, 6 weeks post-1st infusion, & 12-weeks post-initial infusion

Secondary outcomes (2)
  1. Center for Epidemiological Studies-Depression (CES-D)

    Measured: pre-chemotherapy baseline, 6- & 12- weeks post-baseline

  2. Beck Anxiety Inventory (BAI)

    Measured: pre-chemotherapy baseline, 6- & 12-weeks post-baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2008 (estimated)
  2. Study startAug 2006
  3. Primary completionAug 2012
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
471 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00740038
Sponsor's protocol ID
MCC-13782
Other IDs
ACS RSGPB-05-0243-01 (CPPB)
Status last verified
Aug 2011
First submitted
21 Aug 2008
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
No

Publications

  • Courneya KS, Mackey JR, & Quinney HA. Neoplasms. In Myers, Herbert, Humphrey (eds): American College of Sports Medicine resources for clinical exercise physiology: musculoskeletal, neuromuscular, immunologic, and hematologic conditions. New York: Lippincott.

  • Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003 May 1;21(9):1660-8. doi: 10.1200/JCO.2003.04.093.

    PubMed 12721239
  • Courneya KS, Friedenreich CM, Sela RA, Quinney HA, Rhodes RE, Handman M. The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes. Psychooncology. 2003 Jun;12(4):357-74. doi: 10.1002/pon.658.

    PubMed 12748973
  • Jacobsen PB, Meade CD, Stein KD, Chirikos TN, Small BJ, Ruckdeschel JC. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol. 2002 Jun 15;20(12):2851-62. doi: 10.1200/JCO.2002.08.301.

    PubMed 12065562
  • Phillips KM, Jim HS, Small BJ, Tanvetyanon T, Roberts WS, Jacobsen PB. Effects of self-directed stress management training and home-based exercise on stress management skills in cancer patients receiving chemotherapy. Stress Health. 2012 Dec;28(5):368-75. doi: 10.1002/smi.2450. Epub 2012 Sep 13.

    PubMed 22972771

Questions about this trial

What is this clinical trial studying?

A study testing Stress Management training, Exercise Training and Combined stress management and exercise training in people with Quality of Life and Cancer, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Medical Outcomes Survey-Short Form (SF-36, acute) (time frame: pre-chemotherapy baseline, 6 weeks post-1st infusion, & 12-weeks post-initial infusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00740038, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in